Erschienen in:
01.08.2015 | Original Article
TPX2 Level Correlates with Hepatocellular Carcinoma Cell Proliferation, Apoptosis, and EMT
verfasst von:
Bo Liang, Chunhong Jia, Yu Huang, Hua He, Jialu Li, Hui Liao, Xiao Liu, Xincheng Liu, Xiaochun Bai, Dinghua Yang
Erschienen in:
Digestive Diseases and Sciences
|
Ausgabe 8/2015
Einloggen, um Zugang zu erhalten
Abstract
Background
Targeting protein for Xklp2 (TPX2) is a microtubule-associated protein involved in targeting the motor protein Xklp2 to microtubules. TPX2 overexpression plays a key role in the progression of human cancers. But the underlying mechanism remains unclear.
Aims
This study aimed to investigate the effects and mechanisms of TPX2 on the cell cycle, apoptosis, and epithelial–mesenchymal transition (EMT) in hepatocellular carcinoma (HCC).
Methods
The tissue TPX2 mRNA and protein were assessed by quantitative reverse transcriptase PCR and immunoblot. Cell proliferation, cell cycle, apoptosis, and invasion were determined by CCK-8, FACS, TdT-UTP nick end-labeling, and transwell assays. Immunoblotting was performed to detect the expression of target proteins.
Results
TPX2 was highly expressed in tumor tissues compared with non-tumoral tissues, and TPX2 overexpression was positively correlated with poor prognosis. Knockdown TPX2 effectively reduced cell growth, G2/M arrest, induced apoptosis and cell death, and inhibited EMT. Mechanistically, in the TPX2-siRNA-treated groups, cell-cycle-related proteins cyclin A1, cyclin B1, cyclin E1, and cdk4 were up-regulated, while cyclin D1, cdk2, and p21 proteins were down-regulated. Cell-apoptosis-related proteins Bax, p53, caspase-3, and caspase-8 levels were increased. EMT-related proteins E-cadherin was up-regulated, while N-cadherin, β-catenin, MMP-9, MMP-2, and Slug were down-regulated. We also found that knockdown TPX2 in HCC cell lines caused a significant decrease in the level of p-Akt and p-ERK which are important signaling pathways in tumor formation.
Conclusions
TPX2 expression is associated with proliferation, apoptosis, and EMT in hepatocellular carcinoma cell and patients.